INCYTE CORP (INCY) Fundamental Analysis & Valuation

NASDAQ:INCY • US45337C1027

Current stock price

97.74 USD
+2.02 (+2.12%)
At close:
96.2 USD
-1.54 (-1.58%)
After Hours:

This INCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. INCY Profitability Analysis

1.1 Basic Checks

  • In the past year INCY was profitable.
  • INCY had a positive operating cash flow in the past year.
  • INCY had positive earnings in each of the past 5 years.
  • INCY had a positive operating cash flow in each of the past 5 years.
INCY Yearly Net Income VS EBIT VS OCF VS FCFINCY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • With an excellent Return On Assets value of 18.49%, INCY belongs to the best of the industry, outperforming 95.73% of the companies in the same industry.
  • INCY's Return On Equity of 24.90% is amongst the best of the industry. INCY outperforms 95.92% of its industry peers.
  • INCY has a better Return On Invested Capital (19.49%) than 97.48% of its industry peers.
  • INCY had an Average Return On Invested Capital over the past 3 years of 10.37%. This is significantly below the industry average of 28.06%.
  • The last Return On Invested Capital (19.49%) for INCY is above the 3 year average (10.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.49%
ROE 24.9%
ROIC 19.49%
ROA(3y)9.3%
ROA(5y)10.59%
ROE(3y)12.45%
ROE(5y)14.06%
ROIC(3y)10.37%
ROIC(5y)10.71%
INCY Yearly ROA, ROE, ROICINCY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Profit Margin of INCY (25.03%) is better than 93.40% of its industry peers.
  • INCY's Profit Margin has improved in the last couple of years.
  • The Operating Margin of INCY (26.12%) is better than 94.56% of its industry peers.
  • In the last couple of years the Operating Margin of INCY has grown nicely.
  • With an excellent Gross Margin value of 93.26%, INCY belongs to the best of the industry, outperforming 93.59% of the companies in the same industry.
  • INCY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.12%
PM (TTM) 25.03%
GM 93.26%
OM growth 3Y13.93%
OM growth 5YN/A
PM growth 3Y35.6%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.55%
INCY Yearly Profit, Operating, Gross MarginsINCY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INCY Health Analysis

2.1 Basic Checks

  • INCY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, INCY has more shares outstanding
  • Compared to 5 years ago, INCY has less shares outstanding
  • INCY has a better debt/assets ratio than last year.
INCY Yearly Shares OutstandingINCY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
INCY Yearly Total Debt VS Total AssetsINCY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 8.41 indicates that INCY is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 8.41, INCY is doing good in the industry, outperforming 78.83% of the companies in the same industry.
  • The Debt to FCF ratio of INCY is 0.03, which is an excellent value as it means it would take INCY, only 0.03 years of fcf income to pay off all of its debts.
  • INCY has a Debt to FCF ratio of 0.03. This is amongst the best in the industry. INCY outperforms 96.50% of its industry peers.
  • INCY has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • INCY's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. INCY outperforms 46.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 8.41
ROIC/WACC2.06
WACC9.44%
INCY Yearly LT Debt VS Equity VS FCFINCY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • INCY has a Current Ratio of 3.32. This indicates that INCY is financially healthy and has no problem in meeting its short term obligations.
  • INCY has a Current ratio of 3.32. This is comparable to the rest of the industry: INCY outperforms 40.39% of its industry peers.
  • A Quick Ratio of 3.25 indicates that INCY has no problem at all paying its short term obligations.
  • INCY's Quick ratio of 3.25 is in line compared to the rest of the industry. INCY outperforms 41.75% of its industry peers.
Industry RankSector Rank
Current Ratio 3.32
Quick Ratio 3.25
INCY Yearly Current Assets VS Current LiabilitesINCY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. INCY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 414.39% over the past year.
  • INCY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.67% yearly.
  • Looking at the last year, INCY shows a very strong growth in Revenue. The Revenue has grown by 21.22%.
  • INCY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.03% yearly.
EPS 1Y (TTM)414.39%
EPS 3Y34.67%
EPS 5YN/A
EPS Q2Q%25.87%
Revenue 1Y (TTM)21.22%
Revenue growth 3Y14.84%
Revenue growth 5Y14.03%
Sales Q2Q%27.84%

3.2 Future

  • INCY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -9.23% yearly.
  • The Revenue is expected to decrease by -0.83% on average over the next years.
EPS Next Y13.99%
EPS Next 2Y16%
EPS Next 3Y11.72%
EPS Next 5Y-9.23%
Revenue Next Year11.88%
Revenue Next 2Y11.43%
Revenue Next 3Y8.54%
Revenue Next 5Y-0.83%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INCY Yearly Revenue VS EstimatesINCY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
INCY Yearly EPS VS EstimatesINCY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. INCY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.39, which indicates a correct valuation of INCY.
  • Based on the Price/Earnings ratio, INCY is valued cheaper than 96.12% of the companies in the same industry.
  • INCY is valuated rather cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 12.63, INCY is valued correctly.
  • Based on the Price/Forward Earnings ratio, INCY is valued cheaper than 97.67% of the companies in the same industry.
  • INCY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.39
Fwd PE 12.63
INCY Price Earnings VS Forward Price EarningsINCY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INCY is valued cheaper than 96.12% of the companies in the same industry.
  • 97.09% of the companies in the same industry are more expensive than INCY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.36
EV/EBITDA 10.46
INCY Per share dataINCY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • INCY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of INCY may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y16%
EPS Next 3Y11.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INCY Dividend Analysis

5.1 Amount

  • INCY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INCY Fundamentals: All Metrics, Ratios and Statistics

INCYTE CORP

NASDAQ:INCY (4/28/2026, 8:00:02 PM)

After market: 96.2 -1.54 (-1.58%)

97.74

+2.02 (+2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-28
Earnings (Next)N/A
Inst Owners104.89%
Inst Owner Change-0.13%
Ins Owners0.92%
Ins Owner Change-4.16%
Market Cap19.45B
Revenue(TTM)5.14B
Net Income(TTM)1.29B
Analysts73.94
Price Target109.33 (11.86%)
Short Float %6.14%
Short Ratio7.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.64%
Min EPS beat(2)-8.46%
Max EPS beat(2)33.74%
EPS beat(4)3
Avg EPS beat(4)10.48%
Min EPS beat(4)-8.46%
Max EPS beat(4)33.74%
EPS beat(8)3
Avg EPS beat(8)-1.32%
EPS beat(12)5
Avg EPS beat(12)-4.16%
EPS beat(16)7
Avg EPS beat(16)-3.27%
Revenue beat(2)2
Avg Revenue beat(2)7.99%
Min Revenue beat(2)6.72%
Max Revenue beat(2)9.27%
Revenue beat(4)4
Avg Revenue beat(4)5.84%
Min Revenue beat(4)3.45%
Max Revenue beat(4)9.27%
Revenue beat(8)6
Avg Revenue beat(8)2.66%
Revenue beat(12)7
Avg Revenue beat(12)0.75%
Revenue beat(16)9
Avg Revenue beat(16)0.81%
PT rev (1m)0.01%
PT rev (3m)5%
EPS NQ rev (1m)-2.22%
EPS NQ rev (3m)-15.62%
EPS NY rev (1m)1.06%
EPS NY rev (3m)-3.67%
Revenue NQ rev (1m)-1.65%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)0.83%
Valuation
Industry RankSector Rank
PE 14.39
Fwd PE 12.63
P/S 3.78
P/FCF 14.36
P/OCF 13.76
P/B 3.76
P/tB 3.96
EV/EBITDA 10.46
EPS(TTM)6.79
EY6.95%
EPS(NY)7.74
Fwd EY7.92%
FCF(TTM)6.81
FCFY6.96%
OCF(TTM)7.1
OCFY7.27%
SpS25.83
BVpS25.97
TBVpS24.71
PEG (NY)1.03
PEG (5Y)N/A
Graham Number62.9837 (-35.56%)
Profitability
Industry RankSector Rank
ROA 18.49%
ROE 24.9%
ROCE 24.67%
ROIC 19.49%
ROICexc 56.96%
ROICexgc 65.8%
OM 26.12%
PM (TTM) 25.03%
GM 93.26%
FCFM 26.35%
ROA(3y)9.3%
ROA(5y)10.59%
ROE(3y)12.45%
ROE(5y)14.06%
ROIC(3y)10.37%
ROIC(5y)10.71%
ROICexc(3y)33.39%
ROICexc(5y)32.41%
ROICexgc(3y)39.93%
ROICexgc(5y)39.19%
ROCE(3y)13.12%
ROCE(5y)13.56%
ROICexgc growth 3Y17.25%
ROICexgc growth 5YN/A
ROICexc growth 3Y20.23%
ROICexc growth 5YN/A
OM growth 3Y13.93%
OM growth 5YN/A
PM growth 3Y35.6%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.55%
F-Score7
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.02
Cap/Depr 63.1%
Cap/Sales 1.15%
Interest Coverage 250
Cash Conversion 98.43%
Profit Quality 105.28%
Current Ratio 3.32
Quick Ratio 3.25
Altman-Z 8.41
F-Score7
WACC9.44%
ROIC/WACC2.06
Cap/Depr(3y)66.35%
Cap/Depr(5y)125.36%
Cap/Sales(3y)1.35%
Cap/Sales(5y)2.48%
Profit Quality(3y)315.54%
Profit Quality(5y)253.68%
High Growth Momentum
Growth
EPS 1Y (TTM)414.39%
EPS 3Y34.67%
EPS 5YN/A
EPS Q2Q%25.87%
EPS Next Y13.99%
EPS Next 2Y16%
EPS Next 3Y11.72%
EPS Next 5Y-9.23%
Revenue 1Y (TTM)21.22%
Revenue growth 3Y14.84%
Revenue growth 5Y14.03%
Sales Q2Q%27.84%
Revenue Next Year11.88%
Revenue Next 2Y11.43%
Revenue Next 3Y8.54%
Revenue Next 5Y-0.83%
EBIT growth 1Y1102.71%
EBIT growth 3Y30.84%
EBIT growth 5YN/A
EBIT Next Year17.65%
EBIT Next 3Y17.42%
EBIT Next 5Y-9.47%
FCF growth 1Y443.87%
FCF growth 3Y14.94%
FCF growth 5YN/A
OCF growth 1Y321.52%
OCF growth 3Y13.38%
OCF growth 5YN/A

INCYTE CORP / INCY Fundamental Analysis FAQ

What is the fundamental rating for INCY stock?

ChartMill assigns a fundamental rating of 7 / 10 to INCY.


What is the valuation status of INCYTE CORP (INCY) stock?

ChartMill assigns a valuation rating of 7 / 10 to INCYTE CORP (INCY). This can be considered as Undervalued.


Can you provide the profitability details for INCYTE CORP?

INCYTE CORP (INCY) has a profitability rating of 9 / 10.


What is the valuation of INCYTE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INCYTE CORP (INCY) is 14.39 and the Price/Book (PB) ratio is 3.76.